CLASS II ONGOING Device recall · Reported 9 Sep 2026 · FDA Enforcement Report

Philips Brilliance recalled by Philips North America

Philips North America is recalling Philips Brilliance. The recall was initiated on 7 Aug 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI for Brilliance iCT: (01)00884838059474, UDI for Brilliance iCT Upgrades: N/A, UDI for Brilliance iCT SP: N/A.
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3040-2026
FDA event ID
99784
Recalling firm
Philips North America, Cambridge, MA
Classification
Class II
Status
Ongoing
Recall initiated
7 Aug 2026
FDA classified
1 Sep 2026
Reported
9 Sep 2026
Type
FDA Mandated
Customers notified by
N/A
Reason category
Device Malfunction
Device type
Medical Software

Timeline

7 Aug 2026Recall initiated by company
1 Sep 2026Classified by FDA+25 days
9 Sep 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Philips Brilliance. Models: Brilliance iCT, Brilliance iCT Upgrades, Brilliance iCT SP. Software 4.1.10.x Product Codes: 728306, 728305, 728311.

Where it was distributed

US and US Territories.

Questions about this recall

Is Philips Brilliance recalled?

Yes. Philips North America recalled Philips Brilliance on 7 Aug 2026. The recall is Class II and its status is Ongoing. Recall number Z-3040-2026.

Why was it recalled?

Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.

Which lots are affected?

UDI for Brilliance iCT: (01)00884838059474, UDI for Brilliance iCT Upgrades: N/A, UDI for Brilliance iCT SP: N/A.

Where was it sold?

US and US Territories.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips North America

All 531

Other Medical Software recalls

All 903